Package 50242-175-07

{"route": ["ORAL"], "spl_id": "a0597961-b4b9-47ec-961a-919fa9ffba95", "openfda": {"nui": ["N0000194059", "N0000194060", "N0000009533", "N0000191423", "N0000193932"], "unii": ["76RS4S2ET1"], "rxcui": ["2390940", "2390946", "2705365", "2705369"], "spl_set_id": ["eceb9a99-7191-4be5-87c3-0102707cf98e"], "pharm_class_pe": ["Increased Protein Synthesis [PE]"], "pharm_class_epc": ["Survival of Motor Neuron 2 Splicing Modifier [EPC]"], "pharm_class_moa": ["Survival of Motor Neuron 2 Splicing Modifiers [MoA]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]"], "manufacturer_name": ["Genentech, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (50242-175-07)  / 80 mL in 1 BOTTLE, GLASS", "package_ndc": "50242-175-07", "marketing_start_date": "20200807"}], "brand_name": "EVRYSDI", "product_id": "50242-175_a0597961-b4b9-47ec-961a-919fa9ffba95", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Increased Protein Synthesis [PE]", "Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]", "Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]", "Survival of Motor Neuron 2 Splicing Modifier [EPC]", "Survival of Motor Neuron 2 Splicing Modifiers [MoA]"], "product_ndc": "50242-175", "generic_name": "Risdiplam", "labeler_name": "Genentech, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EVRYSDI", "active_ingredients": [{"name": "RISDIPLAM", "strength": ".75 mg/mL"}], "application_number": "NDA213535", "marketing_category": "NDA", "marketing_start_date": "20200807", "listing_expiration_date": "20271231"}